Due to an error in the calculation of the biannually review of the round lots it has been necessary to make a recalculation resulting in changes for seven Danish equities: D/S Norden, DSV, Genmab, NKT Holding, Novo Nordisk B, Coloplast B and Bang & Olufsen B. Please see the enclosed.
Amendment to round lots for certain Danish equities effective from today 25 June 2008
| Source: Nasdaq Copenhagen A/S
Attachments
